Wai-Nga Chan Yun-Ching Huang Dong-Ru Ho Chih-Shou Chen
10.3389/fonc.2022.985177
Front Oncol
2022 Sep 23;12:985177.
case report immune checkpoint inhibitors kidney sparing neoadjuvant immunotherapy upper tract urothelial carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36212396/
Case Reports
PMC9539752
36212396
Case Report: Neoadjuvant immunotherapy with pembrolizumab alone for bilateral upper tract urothelial carcinoma is a feasible strategy for kidney sparing and avoidance of hemodialysis
2022